Obesity Clinic, Meuhedet Health Services, Jerusalem, Israel.
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Int J Obes (Lond). 2011 Jun;35(6):785-792. doi: 10.1038/ijo.2010.217. Epub 2010 Nov 2.
Over 75% of obese subjects fail to maintain their weight following weight loss interventions. We aimed to identify phenotypic and genetic markers associated with weight maintenance/regain following a dietary intervention.
In the 2-year Dietary Intervention Randomized Controlled Trial, we assessed potential predictors for weight changes during the 'weight loss phase' (0-6 months) and the 'weight maintenance/regain phase' (7-24 months). Genetic variation between study participants was studied using single-nucleotide polymorphisms in the leptin gene (LEP).
Mean weight reduction was -5.5% after 6 months, with a mean weight regain of 1.2% of baseline weight during the subsequent 7-24 months. In a multivariate regression model, higher baseline high-molecular-weight adiponectin was the only biomarker predictor of greater success in 0- to 6-month weight loss (β = -0.222, P-value = 0.044). In a multivariate regression model adjusted for 6-month changes in weight and various biomarkers, 6-month plasma leptin reduction exhibited the strongest positive association with 6-month weight loss (β = 0.505, P-value < 0.001). Conversely, 6-month plasma leptin reduction independently predicted weight regain during the following 18 months (β = -0.131, P-value < 0.013). Weight regain was higher among participants who had a greater (top tertiles) 6-month decrease in both weight and leptin (+3.4% (95% confidence interval 2.1-4.8)) as compared with those in the lowest combined tertiles (+0.2% (95% confidence interval -1.1 to 1.4)); P-value < 0.001. Weight regain was further significantly and independently associated with genetic variations in LEP (P = 0.006 for both rs4731426 and rs2071045). Adding genetic data to the phenotypic multivariate model increased its predictive value for weight regain by 34%.
Although greater reduction in leptin concentrations during the initial phase of a dietary intervention is associated with greater weight loss in the short term, plasma leptin reduction, combined with the degree of initial weight loss and with genetic variations in the LEP gene, constitutes a significant predictor of subsequent long-term weight regain.
超过 75%的肥胖患者在减肥干预后无法维持体重。我们旨在确定与饮食干预后体重维持/增加相关的表型和遗传标志物。
在为期 2 年的饮食干预随机对照试验中,我们评估了在“减肥阶段(0-6 个月)”和“体重维持/增加阶段(7-24 个月)”期间体重变化的潜在预测因子。使用瘦素基因(LEP)中的单核苷酸多态性研究研究参与者之间的遗传变异。
6 个月后平均体重减轻 5.5%,随后 7-24 个月内基线体重平均增加 1.2%。在多变量回归模型中,较高的基线高分子量脂联素是 0-6 个月体重减轻更成功的唯一生物标志物预测因子(β=-0.222,P 值=0.044)。在调整了 6 个月体重和各种生物标志物变化的多变量回归模型中,6 个月时血浆瘦素降低与 6 个月时体重减轻呈最强正相关(β=0.505,P 值<0.001)。相反,6 个月时血浆瘦素降低独立预测接下来 18 个月的体重增加(β=-0.131,P 值<0.013)。与体重和瘦素下降幅度最低的 tertiles 相比,6 个月时体重和瘦素下降幅度较大(top tertiles)的参与者体重增加幅度更高(增加 3.4%(95%置信区间 2.1-4.8))(增加 0.2%(95%置信区间 -1.1 至 1.4));P 值<0.001)。体重增加与 LEP 中的遗传变异显著且独立相关(rs4731426 和 rs2071045 的 P 值均为 0.006)。将遗传数据添加到表型多变量模型中,增加了其对体重增加的预测值 34%。
尽管饮食干预的初始阶段瘦素浓度的更大降低与短期体重减轻相关,但血浆瘦素降低,结合初始体重减轻程度和 LEP 基因的遗传变异,是随后长期体重增加的重要预测因子。